|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 284.25 INR | +2.12% |
|
-3.38% | +36.56% |
| 05-20 | Viyash Scientific Limited, Q4 2026 Earnings Call, May 20, 2026 | |
| 05-19 | Viyash Scientific March-quarter consol net profit 521.1 million rupees | RE |
| Market Cap | 124B 1.3B 1.14B 1.05B 969M 1.83B 1.87B 12.55B 4.92B 60.93B 4.87B 4.76B 210B | P/E 2026 |
45.7x | P/E 2027 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 127B 1.33B 1.16B 1.08B 992M 1.88B 1.91B 12.86B 5.04B 62.41B 4.99B 4.88B 216B | EV / Sales 2026 |
2.4x | EV / Sales 2027 * | 3.18x |
| Free-Float |
32.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Viyash Scientific Limited
| 1 day | +2.12% | ||
| 1 week | -3.38% | ||
| Current month | +2.73% | ||
| 1 month | +13.72% | ||
| 3 months | +35.97% | ||
| 6 months | +47.66% | ||
| Current year | +36.56% |
| 1 week | 268.2 |  | 291.15 |
| 1 month | 242.55 | | 297.9 |
| Current year | 178.4 | | 297.9 |
| 1 year | 166.2 | | 297.9 |
| 3 years | 86.03 | | 297.9 |
| 5 years | 61.8 | | 319 |
| 10 years | 42.45 | | 336.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 15/12/2025 | |
Ramakant Singani
DFI | Director of Finance/CFO | - | 31/12/2025 |
| Chief Tech/Sci/R&D Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | - | |
| Director/Board Member | 66 | 24/08/2020 | |
| Director/Board Member | - | 15/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.12% | -3.38% | +54.19% | +220.57% | 1.27B | |
| +0.02% | -0.94% | +48.73% | +173.48% | 1,060B | |
| +0.43% | -0.40% | +64.70% | +62.63% | 619B | |
| -0.67% | -3.23% | +28.72% | +84.53% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -1.73% | -2.59% | +20.17% | +56.79% | 196B | |
| +0.68% | +0.71% | +16.45% | +70.16% | 161B | |
| Average | -0.12% | -3.54% | +28.19% | +72.31% | 357.52B | |
| Weighted average by Cap. | -0.26% | -3.10% | +35.69% | +84.24% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 33.72B 352M 309M 286M 263M 498M 508M 3.41B 1.34B 16.56B 1.32B 1.29B 57.19B | 38.99B 407M 357M 331M 305M 576M 587M 3.94B 1.55B 19.15B 1.53B 1.5B 66.13B |
| Net income | 2.18B 22.78M 19.98M 18.5M 17.02M 32.2M 32.83M 221M 86.49M 1.07B 85.53M 83.66M 3.7B | 3.83B 40.04M 35.12M 32.53M 29.93M 56.61M 57.71M 388M 152M 1.88B 150M 147M 6.5B |
| Net Debt | 3.02B 31.54M 27.67M 25.62M 23.58M 44.59M 45.46M 305M 120M 1.48B 118M 116M 5.12B | - |
Employees
1,244
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | ₹284.25 | +2.12% | 63,490 |
| 10/07/26 | ₹278.35 | -0.89% | 47,034 |
| 09/07/26 | ₹280.85 | +3.63% | 79,832 |
| 08/07/26 | ₹271.00 | -2.87% | 112,804 |
| 07/07/26 | ₹279.00 | -3.59% | 79,383 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
284.25INR
Average target price
312.67INR
Spread / Average Target
+10.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIYASH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
